Core Insights - The U.S. equity markets in Q4 2025 were influenced by optimism regarding potential monetary easing and caution related to economic growth and valuations [1] - The Meridian Growth Fund reported a quarterly return of -0.39%, underperforming the Russell 2500 Growth Index which returned 0.33% [1] - The Fund's focus remains on high-quality businesses with strong competitive advantages and sustainable earnings growth as it approaches 2026 [1] Company Highlights - Globus Medical, Inc. (NYSE:GMED) was highlighted as a leading contributor to the Meridian Growth Fund, focusing on healthcare solutions for musculoskeletal disorders [2] - The stock of Globus Medical, Inc. had a one-month return of 5.77% and a 52-week gain of 0.04%, closing at $92.98 per share with a market capitalization of $12.558 billion on January 26, 2026 [2] - The company reported a re-acceleration in its core spine business to double-digit growth, with evidence of renewed market share gains and improved operating leverage expected in 2026 [3]